Cite

HARVARD Citation

    Sayama, H. et al. (2021). Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer. CPT: pharmacometrics & systems pharmacology. pp. 864-877. [Online]. 
  
Back to record